| 6Q3Z: reference: Designing Dual Inhibitors of Anaplastic Lymphoma Kinase (ALK) and Bromodomain-4 (BRD4) by Tuning Kinase Selectivity., Watts E, Heidenreich D, Tucker E, Raab M, Strebhardt K, Chesler L, Knapp S, Bellenie B, Hoelder S, J Med Chem. 2019 Feb 21. doi: 10.1021/acs.jmedchem.8b01947. PMID: 30789735 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).